Trevi Therapeutics
TRVI
TRVI
80 hedge funds and large institutions have $178M invested in Trevi Therapeutics in 2024 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 16 increasing their positions, 27 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7.26% less ownership
Funds ownership: 82.03% → 74.77% (-7.3%)
41% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 27
Holders
80
Holding in Top 10
–
Calls
$8K
Puts
$2K
Top Buyers
| 1 | +$7.59M | |
| 2 | +$4.63M | |
| 3 | +$897K | |
| 4 |
SAM
Simplify Asset Management
Las Vegas,
Nevada
|
+$690K |
| 5 |
SC
Shay Capital
New York
|
+$392K |
Top Sellers
| 1 | -$4.25M | |
| 2 | -$3.23M | |
| 3 | -$2.71M | |
| 4 |
Renaissance Technologies
New York
|
-$1.47M |
| 5 |
Morgan Stanley
New York
|
-$793K |